JOSÉ LUIS
CABRIADA NUÑO
Chercheur jusqu' 2022
Publications dans lesquelles il/elle collabore avec IAGO RODRÍGUEZ LAGO (34)
2024
-
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresis
Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 347-351
-
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study
Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733
-
Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study
Gastroenterologia y Hepatologia
-
Environmental Exposure to Trace Elements and Heavy Metals Preceding the Clinical Onset of Inflammatory Bowel Disease
Crohn's and Colitis 360, Vol. 6, Núm. 1
-
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612
-
Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn’s disease: a case-control study
International Journal of Colorectal Disease, Vol. 39, Núm. 1
2023
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
-
Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
United European Gastroenterology Journal, Vol. 11, Núm. 1, pp. 9-18
2022
-
Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU
Journal of Crohn's & colitis, Vol. 16, Núm. 7, pp. 1049-1058
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy
Gastroenterology
-
Increased use of healthcare resources during the preclinical period of inflammatory bowel disease
Digestive and Liver Disease
2020
-
Apoptotic colitis owing to dolutegravir
Gastroenterologia y Hepatologia
-
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain)
Gastroenterology, Vol. 159, Núm. 2, pp. 781-783
-
Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry (Surgical Endoscopy, (2020), 34, 3, (1112-1122), 10.1007/s00464-019-06858-z)
Surgical Endoscopy
-
Early microscopic findings in preclinical inflammatory bowel disease
Digestive and Liver Disease, Vol. 52, Núm. 12, pp. 1467-1472
-
Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry
Surgical Endoscopy, Vol. 34, Núm. 3, pp. 1112-1122
-
Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 43, Núm. 10, pp. 614-619
-
Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease
Gastroenterologia y Hepatologia, Vol. 43, Núm. 8, pp. 439-445